Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.

In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by startups Circadia Health and Preceptis Medical, which both saw expedited approval from the FDA due to the pandemic.

Circadia Health earned a spot on this year’s “20 medical device startups you need to know” list.

Circadia CEO Fares Siddiqui discusses the quick approval that came for his company’s C100 system that uses radar to monitor respiratory function.

Preceptis Medical CEO Steve Anderson, meanwhile, explains why the agency – and he hopes payers – want to see his company’s ear-tube implanting system on the market.

We also visit with Heidi Dohse, senior program manager at Google’s Cloud Healthcare & Life Sciences organization, who will be leading the upcoming DeviceTalks Tuesday’s discussion about how medtech devices can use data to better serve its sickest patients.

Register for the free discussion…

Read more
  • 0

Why FDA put the pedal to the metal for radar and hummingbirds and why medtech needs Google

In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by startups Circadia Health and Preceptis Medical, which both saw expedited approval from the FDA due to the pandemic.

Circadia Health earned a spot on this year’s “20 medical device startups you need to know” list.

Circadia CEO Fares Siddiqui discusses the quick approval that came for his company’s C100 system that uses radar to monitor respiratory function.

Preceptis Medical CEO Steve Anderson, meanwhile, explains why the agency – and he hopes payers – want to see his company’s ear-tube implanting system on the market.

We also visit with Heidi Dohse, senior program manager at Google’s Cloud Healthcare & Life Sciences organization, who will be leading the upcoming DeviceTalks Tuesday’s discussion about how medtech devices can use data to better serve its sickest patients.

Register for the free discussion…

Read more
  • 0

FDA OKs Circadia’s radar-powered tool in battle against COVID-19

Circadia’s C100 System [Image courtesy of Circadia]

Healthcare staff monitoring COVID-19 patients for respiratory distress will have a new radar-powered tool at their disposal thanks to an expedited FDA clearance for Circadia Health.

London-based Circadia Health announced today the agency gave a green light to its Contactless Respiration Rate (CResp) monitoring systems and c100 device.

“Our C100 uses radar to wirelessly look at your breathing pattern from up to four feet away,” says Fares Siddiqui, co-founder and CEO of Circadia, told the DeviceTalks Weekly podcast. “From that we can pick up your respiratory rate and patterns and then apply machine learning in order to predict and prevent respiratory complications.”

For example, Siddiqui said, “breathlessness” is one of the early signs of distress in COVID-19 patients. “We can pick that up and enable …

Read more
  • 0

FDA OKs Circadia’s radar-powered tool in battle against COVID-19

Circadia’s C100 System [Image courtesy of Circadia]

Healthcare staff monitoring COVID-19 patients for respiratory distress will have a new radar-powered tool at their disposal thanks to an expedited FDA clearance for Circadia Health.

London-based Circadia Health announced today the agency gave a green light to its Contactless Respiration Rate (CResp) monitoring systems and c100 device.

“Our C100 uses radar to wirelessly look at your breathing pattern from up to four feet away,” says Fares Siddiqui, co-founder and CEO of Circadia, told the DeviceTalks Weekly podcast. “From that we can pick up your respiratory rate and patterns and then apply machine learning in order to predict and prevent respiratory complications.”

For example, Siddiqui said, “breathlessness” is one of the early signs of distress in COVID-19 patients. “We can pick that up and enable …

Read more
  • 0